Tauriga Sciences Inc (TAUG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,134 | -251 | -5,089 | -4,698 | -3,341 |
| Depreciation Amortization | 6 | 3 | 45 | 42 | 40 |
| Accounts payable and accrued liabilities | 32 | 43 | -23 | -21 | -25 |
| Other Working Capital | -8 | 34 | -41 | -134 | 21 |
| Other Operating Activity | 1,791 | 44 | 3,263 | 3,209 | 2,234 |
| Operating Cash Flow | $-313 | $-127 | $-1,845 | $-1,602 | $-1,072 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -12 | -12 | -11 |
| Net Acquisitions | 1 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | -28 | -28 | -28 |
| Investing Cash Flow | $1 | $N/A | $-40 | $-40 | $-39 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 407 | 233 | N/A | 0 | N/A |
| Common Stock Issued | N/A | N/A | 1,369 | 1,229 | 788 |
| Other Financing Activity | -230 | -230 | -139 | -83 | -83 |
| Financing Cash Flow | $177 | $3 | $1,229 | $1,145 | $704 |
| Exchange Rate Effect | -1 | 0 | 52 | 1 | -1 |
| Beginning Cash Position | 209 | 209 | 813 | 813 | 813 |
| End Cash Position | 74 | 85 | 209 | 316 | 405 |
| Net Cash Flow | $-135 | $-124 | $-604 | $-497 | $-408 |
| Free Cash Flow | |||||
| Operating Cash Flow | -313 | -127 | -1,845 | -1,602 | -1,072 |
| Capital Expenditure | N/A | N/A | -12 | -12 | -11 |
| Free Cash Flow | -313 | -127 | -1,857 | -1,614 | -1,083 |